Outcomes of Counterfeit Drugs in the Prevention and Treatment of Diseases and Organic Dysfunctions in Africa

Addis Demissie
Addis Demissie
Yemane Berhane
Yemane Berhane
Asian Institute of Public Health

Send Message

To: Author

Outcomes of Counterfeit Drugs in the Prevention and Treatment of Diseases and Organic Dysfunctions in Africa

Article Fingerprint

ReserarchID

BK3K2

Outcomes of Counterfeit Drugs in the Prevention and Treatment of Diseases and Organic Dysfunctions in Africa Banner

AI TAKEAWAY

Connecting with the Eternal Ground
  • English
  • Afrikaans
  • Albanian
  • Amharic
  • Arabic
  • Armenian
  • Azerbaijani
  • Basque
  • Belarusian
  • Bengali
  • Bosnian
  • Bulgarian
  • Catalan
  • Cebuano
  • Chichewa
  • Chinese (Simplified)
  • Chinese (Traditional)
  • Corsican
  • Croatian
  • Czech
  • Danish
  • Dutch
  • Esperanto
  • Estonian
  • Filipino
  • Finnish
  • French
  • Frisian
  • Galician
  • Georgian
  • German
  • Greek
  • Gujarati
  • Haitian Creole
  • Hausa
  • Hawaiian
  • Hebrew
  • Hindi
  • Hmong
  • Hungarian
  • Icelandic
  • Igbo
  • Indonesian
  • Irish
  • Italian
  • Japanese
  • Javanese
  • Kannada
  • Kazakh
  • Khmer
  • Korean
  • Kurdish (Kurmanji)
  • Kyrgyz
  • Lao
  • Latin
  • Latvian
  • Lithuanian
  • Luxembourgish
  • Macedonian
  • Malagasy
  • Malay
  • Malayalam
  • Maltese
  • Maori
  • Marathi
  • Mongolian
  • Myanmar (Burmese)
  • Nepali
  • Norwegian
  • Pashto
  • Persian
  • Polish
  • Portuguese
  • Punjabi
  • Romanian
  • Russian
  • Samoan
  • Scots Gaelic
  • Serbian
  • Sesotho
  • Shona
  • Sindhi
  • Sinhala
  • Slovak
  • Slovenian
  • Somali
  • Spanish
  • Sundanese
  • Swahili
  • Swedish
  • Tajik
  • Tamil
  • Telugu
  • Thai
  • Turkish
  • Ukrainian
  • Urdu
  • Uzbek
  • Vietnamese
  • Welsh
  • Xhosa
  • Yiddish
  • Yoruba
  • Zulu
Font Type
Font Size
Font Size
Bedground

Abstract

I would like thank Prof. Yemane Berhane for his close

References

21 Cites in Article
  1. G Jackson,S Arver,I Banks,V Stecher (2010). Counterfeit phosphodiesterase type 5 inhibitors pose significant safety risks.
  2. Francesca Baratta,A,Paola Brusa (2012). Diffusion of counterfeit drugs in developing countries and stability of galenics stored for months under different conditions of temperature and relative humidity.
  3. Amon,Jj (2008). Dangerous medicines: Unproven AIDS cures and counterfeit antiretroviral drugs.
  4. William Roberts (2008). Facts and Ideas from Anywhere.
  5. Who (2010). Growing threat from counterfeit medicines.
  6. May Cheng,Mm (2009). Is the Drugstore Safe? Counterfeit Diabetes Products on the Shelves.
  7. N Paul,Aline Newton Fmfn,Dallas Planc¸on,Michael Mildenhall,Li Green,Eva Ziyong,S Christophel,Stephen Howells,Eric Mcintosh10,Paul Laurin,Nancy Blum,Christina Hampton,K,Leonard Nyadong,C Ray,Budiono Soong,Wang Santoso,John Zhiguang,K Newton (2008). A Collaborative Epidemiological Investigation into the Criminal Fake Artesunate Trade in South East Asia.
  8. Usman Hadi Pvdb,P Erni,Nun Kolopaking,Widjoseno Zairina,Gardjito,, Inge C Gyssens,( Amrin) (2010). tSGARiIPaP. Cross-sectional study of availability and pharmaceutical quality of antibiotics requested with or without prescription (Over The Counter) in Surabaya, Indonesia.
  9. Jap William G Meyer,Duane Hospenthal,Clinton Murray,Kurt Jerke,Anthony Hawksworth,David Metzgar,T,Douglas Walsh,Max Wu,Rosa Ergas,Uzo Chukwuma,Steven Tobias,John Klena,I,Maha Talaat,Ryan Maves,Michael Ellis,Glenn Wortmann,David Blazes,L Lindler (2011). Antimicrobial resistance surveillance in the AFHSC-GEIS network.
  10. Robert Cockburn,Paul Newton,E Agyarko,Dora Akunyili,Nicholas White (2005). The Global Threat of Counterfeit Drugs: Why Industry and Governments Must Communicate the Dangers.
  11. Lucy Reynolds,Martin Mckee (2010). Organised crime and the efforts to combat it: a concern for public health.
  12. Sivong Sengaloundeth,Michael Green,Facundo Fernández,Ot Manolin,Khamlieng Phommavong,Vongsavanh Insixiengmay,Christina Hampton,Leonard Nyadong,Dallas Mildenhall,Dana Hostetler,Lamphet Khounsaknalath,Latsamy Vongsack,Samlane Phompida,Viengxay Vanisaveth,Lamphone Syhakhang,Paul Newton (2009). A stratified random survey of the proportion of poor quality oral artesunate sold at medicine outlets in the Lao PDR – implications for therapeutic failure and drug resistance.
  13. G Aa Amin (2007). ANTIMALARIAL DRUG QUALITY IN AFRICA.
  14. J Christopher,C Whitty,Evelyn Ansah,Toby Leslie,Sarah Staedke (2008). Deployment of ACT antimalarials for treatment of malaria: challenges and opportunities.
  15. Maria Cristina Gaudiano,Adm,Emilia Cocchieri,Eleonora Antoniella,Paola Bertocchi,Stefano Alimonti,Luisa Valvo (2007). Medicines informal market in Congo, Burundi and Angola:counterfeit and substandard antimalarials.
  16. Jimmy Volmink,L (2005). Antimalarial treatment with artemisinin combination therapy in Africa :Desirable, achievable, but not easy.
  17. Jean-Robert Ioset,H (2009). Simple Field Assays to Check Quality of Current Artemisinin-Based Antimalarial Combination Formulations.
  18. N Paul,R Newton,Facundo Fernandez,Michael Green,Manuela Sunjio,Carinne Bruneton,Souly Phanouvong,P Christopher,J Whitty,Ambrose Talisuna,Stephane Proux,Eva Maria Christophel,Grace Malenga,P,Kalifa Bojang,Harparkash Kaur,Kevin Palmer,P Nicholas,Brian Day,François Greenwood,Njw Nosten (2006). Manslaughter by Fake Artesunate in Asia-Will Africa Be Next?.
  19. Obinna Onwujekwe,Harparkash Kaur,Nkem Dike,Elvis Shu,Benjamin Uzochukwu,Kara Hanson,Viola Okoye,Paul Okonkwo (2009). Quality of anti-malarial drugs provided by public and private healthcare providers in south-east Nigeria.
  20. Douglas Macpherson,William Bdg,Shukal Baine,Paul Bala,Paul Gubbins,Ms-N Holtom (2009). Population Mobility, Globalization,and Antimicrobial Drug Resistance.
  21. Amy Sapkota,Mec,Rachel Rosenberg Goldstein,Nancy Atkinson,Shauna Sweet Unknown Title.

Funding

No external funding was declared for this work.

Conflict of Interest

The authors declare no conflict of interest.

Ethical Approval

No ethics committee approval was required for this article type.

Data Availability

Not applicable for this article.

How to Cite This Article

Addis Demissie. 1970. \u201cOutcomes of Counterfeit Drugs in the Prevention and Treatment of Diseases and Organic Dysfunctions in Africa\u201d. Unknown Journal GJMR Volume 12 (GJMR Volume 12 Issue 11).

Download Citation

Journal Specifications
Keywords
Version of record

v1.2

Issue date
January 8, 2013

Language
en
Experiance in AR

Explore published articles in an immersive Augmented Reality environment. Our platform converts research papers into interactive 3D books, allowing readers to view and interact with content using AR and VR compatible devices.

Read in 3D

Your published article is automatically converted into a realistic 3D book. Flip through pages and read research papers in a more engaging and interactive format.

Article Matrices
Total Views: 21020
Total Downloads: 11054
2026 Trends
Related Research
Our website is actively being updated, and changes may occur frequently. Please clear your browser cache if needed. For feedback or error reporting, please email [email protected]

Request Access

Please fill out the form below to request access to this research paper. Your request will be reviewed by the editorial or author team.
X

Quote and Order Details

Contact Person

Invoice Address

Notes or Comments

This is the heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

High-quality academic research articles on global topics and journals.

Outcomes of Counterfeit Drugs in the Prevention and Treatment of Diseases and Organic Dysfunctions in Africa

Addis Demissie
Addis Demissie
Yemane Berhane
Yemane Berhane

Research Journals